Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAxsome Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 7 | -$1.26 | -$0.41 | -$0.84 |
| Q2 2026 | 8 | -$1.65 | $0.16 | -$0.84 |
| Q3 2026 | 7 | -$1.31 | $0.25 | -$0.28 |
| Q4 2026 | 3 | $0.33 | $0.46 | $0.39 |
| Q1 2027 | 3 | $0.09 | $0.12 | $0.10 |
| Q2 2027 | 2 | $0.52 | $0.72 | $0.61 |
| Q3 2027 | 2 | $0.97 | $1.34 | $1.14 |
| Q4 2027 | 2 | $1.41 | $1.96 | $1.66 |
| Q1 2028 | 3 | $2.06 | $2.86 | $2.42 |
| Q2 2028 | 6 | $2.67 | $3.70 | $3.13 |
| Q3 2028 | 5 | $3.13 | $4.33 | $3.67 |
| Q4 2028 | 5 | $3.86 | $5.35 | $4.53 |
Axsome Therapeutics Inc Earnings Date And Information
Axsome Therapeutics Inc last posted its earnings results on Monday, May 4th, 2026. The company reported $-1.26 earnings per share for the quarter, missing analysts' consensus estimates of $-0.85 by $0.41. The company had revenue of 191.20 M for the quarter and had revenue of 638.50 M for the year. Axsome Therapeutics Inc has generated $-4 earnings per share over the last year ($-3.68 diluted earnings per share) and currently has a price-to-earnings ratio of -63.98. Axsome Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Axsome Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | -$0.85 | -$1.26 | -0.41 | $190.91 M | $191.20 M |
| 02/23/2026 | Q4 2025 | -$0.70 | -$0.56 | 0.14 | $193.36 M | $196.00 M |
| 11/03/2025 | Q3 2025 | -$0.82 | -$0.94 | -0.12 | $162.67 M | $170.99 M |
| 08/04/2025 | Q2 2025 | -$1.00 | -$0.97 | 0.03 | $138.02 M | $150.04 M |
| 05/05/2025 | Q1 2025 | -$1.26 | -$1.22 | 0.04 | $119.16 M | $121.46 M |
| 02/18/2025 | Q4 2024 | -$1.00 | -$1.54 | -0.54 | $118.07 M | $118.77 M |
| 11/12/2024 | Q3 2024 | -$1.38 | -$1.34 | 0.04 | $98.37 M | $104.76 M |
| 08/05/2024 | Q2 2024 | -$1.30 | -$1.67 | -0.37 | $86.92 M | $87.17 M |
| 05/06/2024 | Q1 2024 | -$1.20 | -$1.44 | -0.24 | $73.29 M | $75.00 M |
| 02/23/2024 | Q4 2023 | N/A | -$2.08 | N/A | N/A | $71.53 M |
| 11/06/2023 | Q3 2023 | -$1.24 | -$1.32 | -0.08 | N/A | $57.79 M |
| 08/07/2023 | Q2 2023 | -$1.24 | -$1.54 | -0.3 | N/A | $46.70 M |
| 05/08/2023 | Q1 2023 | N/A | -$0.26 | N/A | N/A | $94.58 M |
| 02/27/2023 | Q4 2022 | N/A | -$1.41 | N/A | N/A | $24.37 M |
| 11/07/2022 | Q3 2022 | -$1.10 | -$1.07 | 0.03 | N/A | $16.85 M |
| 08/09/2022 | Q2 2022 | -$1.19 | -$1.06 | 0.13 | N/A | $8.82 M |
| 05/02/2022 | Q1 2022 | -$1.02 | -$1.03 | -0.01 | N/A | $0 |
| 03/01/2022 | Q4 2021 | -$0.99 | -$0.90 | 0.09 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.94 | -$0.93 | 0.01 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.88 | -$0.86 | 0.02 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Axsome Therapeutics Inc Earnings: FAQ's
The conference call for Axsome Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Axsome Therapeutics Inc's latest earnings report can be read online.
Axsome Therapeutics Inc (:AXSM) has a recorded annual revenue of $638.50 M.
Axsome Therapeutics Inc (:AXSM) has a recorded net income of $-183,174,000.Axsome Therapeutics Inc has generated $-3.68 earnings per share over the last four quarters.
Axsome Therapeutics Inc (:AXSM) has a price-to-earnings ratio of -63.98 and price/earnings-to-growth ratio is -1.43.